Algert Global LLC bought a new stake in shares of Mettler-Toledo International Inc. (NYSE:MTD – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,205 shares of the medical instruments supplier’s stock, valued at approximately $4,807,000.
Several other hedge funds have also bought and sold shares of MTD. Family Firm Inc. bought a new position in shares of Mettler-Toledo International during the 2nd quarter valued at approximately $25,000. Blue Trust Inc. increased its stake in shares of Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in shares of Mettler-Toledo International during the 3rd quarter valued at $37,000. Rothschild Investment LLC purchased a new position in shares of Mettler-Toledo International during the 2nd quarter valued at $42,000. Finally, Itau Unibanco Holding S.A. bought a new position in Mettler-Toledo International in the 2nd quarter worth $42,000. Institutional investors own 95.07% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on the company. Robert W. Baird lowered their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Wells Fargo & Company lowered their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Evercore ISI increased their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. lifted their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Finally, Stifel Nicolaus dropped their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $1,338.75.
Insider Buying and Selling at Mettler-Toledo International
In other news, Director Elisha W. Finney sold 76 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. This represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.94% of the company’s stock.
Mettler-Toledo International Stock Performance
Shares of MTD opened at $1,217.97 on Monday. Mettler-Toledo International Inc. has a fifty-two week low of $1,059.08 and a fifty-two week high of $1,546.93. The company’s fifty day moving average is $1,361.85 and its 200 day moving average is $1,399.98. The stock has a market capitalization of $25.70 billion, a PE ratio of 32.84, a P/E/G ratio of 4.02 and a beta of 1.16.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The firm had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. As a group, research analysts forecast that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current year.
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Further Reading
- Five stocks we like better than Mettler-Toledo International
- Most active stocks: Dollar volume vs share volume
- Disney’s Magic Strategy: Reinventing the House of Mouse
- High Flyers: 3 Natural Gas Stocks for March 2022
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- What is the Dow Jones Industrial Average (DJIA)?
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.